Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
BDRX | US
0.28
4.91%
Healthcare
Biotechnology
30/06/2024
21/10/2024
5.98
5.58
6.25
5.56
Biodexa Pharmaceuticals Plc a drug delivery technology company focuses on the bio-delivery and biodistribution of medicines in Belgium and internationally. The company is developing MTX110 a direct delivery treatment for diffuse intrinsic pontine glioma medulloblastomas and glioblastoma multiforme; MTD211 a long-acting formulation of brexpiprazole for the treatment of schizophrenia and adjunctive treatment of major depressive disorder; and MTX223 a long-acting injectable formulations of biologic products such as mAbs or other high molecular weight proteins. It also offers drug delivery platforms such as Q-Sphera a polymer microsphere microtechnology used for sustained release drug delivery; MidaSolve an oligosaccharide nanotechnology used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors; and MidaCore a gold nanoparticle used for targeting sites of disease by using chemotherapeutic agents or immunotherapeutic agents. The company was formerly known as Midatech Pharma plc and changed its name to Biodexa Pharmaceuticals Plc in March 2023. Biodexa Pharmaceuticals Plc was founded in 2000 and is headquartered in Cardiff the United Kingdom.
View LessValue Stock (Price to Book < 3)
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
382.3%1 month
294.8%3 months
178.2%6 months
240.2%-
-
0.29
-
-
0.03
4.70
-
-6.44M
3.47M
3.47M
-
-7.93K
-
-64.10
-97.23
0.95
2.29
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
6.18
Range1M
10.63
Range3M
10.63
Rel. volume
0.15
Price X volume
420.32K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Neurotrope Inc | NTRP | Biotechnology | 2.4 | 3.80M | 0.00% | n/a | 0.00% |
Gritstone Oncology Inc - Ordinary Shares | GRTS | Biotechnology | 0.0322 | 3.80M | -31.78% | n/a | 461.91% |
Sonnet BioTherapeutics Holdings Inc | SONN | Biotechnology | 5.71 | 3.71M | -3.38% | n/a | 5.74% |
Oragenics Inc | OGEN | Biotechnology | 0.345 | 3.63M | 5.83% | n/a | 0.00% |
Virpax Pharmaceuticals Inc | VRPX | Biotechnology | 0.7216 | 3.53M | 6.15% | n/a | 0.00% |
Alaunos Therapeutics Inc | TCRT | Biotechnology | 2.16 | 3.46M | -4.42% | n/a | 0.00% |
QNRX | QNRX | Biotechnology | 0.8646 | 3.44M | 1.72% | n/a | 43.11% |
22nd Century Group Inc | XXII | Biotechnology | 0.105 | 3.30M | 0.10% | n/a | -1072.15% |
Aptevo Therapeutics Inc | APVO | Biotechnology | 0.2389 | 3.21M | 20.35% | n/a | 112.59% |
Galera Therapeutics Inc | GRTX | Biotechnology | 0.0555 | 3.07M | 2.78% | n/a | -0.87% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Forza X1 Inc | FRZA | Recreational Vehicles | 0.19 | 2.99M | -13.68% | n/a | 0.97% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.06 | 2.71M | 0.00% | n/a | 17.32% |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 3.65 | 2.01M | -6.89% | n/a | 0.00% |
Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.011 | 1.01M | 10.00% | n/a | -37.05% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 0.03 | 0.53 | Cheaper |
Ent. to Revenue | 4.70 | 3,967.00 | Cheaper |
PE Ratio | - | 41.03 | - |
Price to Book | 0.29 | 15.55 | Cheaper |
Dividend Yield | - | 2.20 | - |
Std. Deviation (3M) | 178.25 | 72.80 | Riskier |
Debt to Equity | - | -1.23 | - |
Debt to Assets | - | 0.25 | - |
Market Cap | 3.47M | 3.66B | Emerging |